Preventing Skin Cancer

The American Academy of Dermatology recommends these steps to help prevent AKs and skin cancer.

  • Do not try to get a tan from the sun or from tanning beds

    Why:

    UV light from the sun or from tanning beds can cause skin cancer and wrinkling.


    A healthier option:

    Use sunless self-tanning products. Remember, you still need to use sunscreen.

  • Generously apply sunscreen to all exposed skin

    What to do:

    Use a sunscreen that has an SPF (sun protection factor) number of at least 15 and protects against two types of UV rays: UVA and UVB. Reapply the sunscreen every 2 hours if you are outdoors, even if it's cloudy. Also, reapply sunscreen after swimming.

  • Cover up when you must be in the sun

    What to do:

    Keep arms and legs covered—avoid short-sleeved shirts or shorts. Wear a wide-brimmed hat. Choose sunglasses that protect against two types of UV rays: UVA and UVB.

  • Use extra caution near water, snow or sand

    Why:

    These surfaces can reflect the sun's rays and cause sunburn.

  • Examine your skin

    What to do:

    Check your skin monthly for new skin growths or changes to existing freckles, moles or bumps. Report any changes to your doctor.

  • See your doctor for regular skin exams

Important Product Safety Information

SOLARAZE® (diclofenac sodium-3%) Gel is indicated for the topical treatment of actinic keratoses (AKs).

Sun avoidance is indicated during SOLARAZE® Gel therapy. The safety of using sunscreens, cosmetics or topical medications while being treated with SOLARAZE® Gel is not known. Do not get SOLARAZE® Gel into eyes.

As with other non-steroidal anti-inflammatory drugs (NSAIDs), severe allergic reactions may occur in patients without prior exposure to diclofenac. Patients who are allergic or sensitive to aspirin and/or other NSAIDs, who also have asthma and nasal polyps, may have a condition known as the aspirin triad and should tell their doctor before beginning therapy.

SOLARAZE® Gel should be used with caution in patients with active stomach ulcers or bleeding and severe kidney or liver impairments. SOLARAZE® Gel should not be applied to open wounds, skin infections or any skin that shows signs of irritation.

In clinical trials, the most common adverse reactions involved the skin and included contact dermatitis, rash, dry skin and exfoliation (widespread reddened and peeling skin).

SOLARAZE® (diclofenac sodium-3%) Gel Full Prescribing Information.